Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia

Details for Australian Patent Application No. 2010297252 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Chen, Li; Feng, Lichun; Huang, Mengwei; Li, Jia; Nan, Fajun; Pang, Tao; Yu, Lifang; Zhang, Mei

Agent Spruson & Ferguson

Pub. Number AU-A-2010297252

PCT Pub. Number WO2011/033099

Priority PCT/ CN2009/074060 21.09.09 CN

Filing date 20 September 2010

Wipo publication date 24 March 2011

International Classifications

C07D 209/34 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/033099 Priority application(s): WO2011/033099

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010297258-Dosage regimen for administering an EpCAMxCD3 bispecific antibody

2010297248-Method for identifying whether a patient will be responder or not to immunotherapy